Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Dec;31(12):609-16.
doi: 10.1016/j.tins.2008.09.004. Epub 2008 Oct 24.

Mutant huntingtin and mitochondrial dysfunction

Affiliations
Review

Mutant huntingtin and mitochondrial dysfunction

Ella Bossy-Wetzel et al. Trends Neurosci. 2008 Dec.

Abstract

Huntington's disease (HD) is a fatal, inherited neurodegenerative disorder that gradually robs affected individuals of memory, cognitive skills and normal movements. Although research has identified a single faulty gene, the huntingtin gene, as the cause of the disease, a cure remains elusive. Strong evidence indicates that mitochondrial impairment plays a key part in HD pathogenesis. Here, we highlight how mutant huntingtin (mtHtt) might cause mitochondrial dysfunction by either perturbing transcription of nuclear-encoded mitochondrial proteins or by direct interaction with the organelle and modulation of respiration, mitochondrial membrane potential and Ca(2+) buffering. In addition, we propose that mtHtt might convey its neurotoxicity by evoking defects in mitochondrial dynamics, organelle trafficking and fission and fusion, which, in turn, might result in bioenergetic failure and HD-linked neuronal dysfunction and cell death. Finally, we speculate how mitochondria might dictate selective vulnerability of long projection neurons, such as medium spiny neurons, which are particularly affected in HD.

PubMed Disclaimer

Figures

Figure 1
Figure 1
mtHtt impairs mitochondrial function by transcriptional dysregulation of nuclear encoded mitochondrial proteins and by direct effects on the organelle. (1) mtHtt blocks the PGC-1α promoter via inhibition of the CREB transcriptional activator, resulting in decreased PGC-1α expression. (2) Lowered PGC-1α will decrease PPARγ-mediated expression of nuclear encoded mitochondrial proteins that are necessary for respiration and oxidative damage defense. (3) mtHtt can have direct effects on mitochondria, blocking the respiratory complex II, just as 3-NP does. Respiratory inhibition, in turn, leads to decreased energy production and ΔΨm as well as increased ROS generation. The bioenergetic decline caused by transcriptional deregulation and direct effects of mtHtt on mitochondria can cause increased vulnerability to excitotoxic stimuli amplification of the mitochondrial damage by Ca2+-mediated mitochondrial permeability transition pore (mPTP) opening.
Figure 2
Figure 2
ATP-dependent motor proteins, dynein and kinesin, regulate anterograde and retrograde transport of mitochondria in neurons. Htt binds to HAP1, regulating dynein and kinesin function.
Figure 3
Figure 3
Hypothesis that mtHtt impinges on the mitochondrial fission/fusion engine by recruitment into the DRP1/MFN complexes. Mitochondrial fusion allows mixing of metabolites and mtDNA molecules. This process may prevent manifestation of mtDNA mutations by complementation with wild-type mtDNA. mtHtt may abnormally interact with the mitochondrial fission and fusion GTPases, DRP1 or MFN, thereby preventing further mitochondrial fusion or continuous fission. This may have a profound impact on mitochondrial mobility, Ca2+ handling, respiration, ATP production, free radical production and mitochondrial membrane potential. It may also lead to the manifestation of mitochondrial DNA mutations and may sensitize neurons to Ca2+-mediated opening of the mitochondrial permeability transition pore (mPTP) and release of apoptogenic factors like cytochrome c.

References

    1. Goldberg YP, et al. Identification of an Alu retrotransposition event in close proximity to a strong candidate gene for Huntington's disease. Nature. 1993;362:370–373. - PubMed
    1. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell. 1993;72:971–983. - PubMed
    1. Kegel KB, et al. Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription. J Biol Chem. 2002;277:7466–7476. - PubMed
    1. Kegel KB, et al. Huntingtin associates with acidic phospholipids at the plasma membrane. J Biol Chem. 2005;280:36464–36473. - PubMed
    1. Rockabrand E, et al. The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis. Hum Mol Genet. 2007;16:61–77. - PubMed

Publication types